A study led by researchers at the University of Colorado Boulder, published in the journal Exploration of Medicine, is among the first to assess how cannabis bought over the counter at dispensaries—rather than government-supplied or synthetic varieties—impacts cancer symptoms or chemotherapy side effects.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe